Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Jan

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb

Featured Webinar

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Main menu

Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

To read the full story....

Breaking News

NantHealth Receives Nasdaq Delisting Notice

In Brief This Week: WHO, Cancer Genetics, Interpace Diagnostics, and More

Biocept Prices $2.2M Registered Direct Offering

Medicare Covers Adaptive Biotechnologies' ClonoSeq Assay

Coverage of Quest Diagnostics, LabCorp Started by UBS

FDA Finalizes Guidance on Coordinated Development of Antimicrobial Drugs, Susceptibility Tests

Featured White Papers

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

What's Popular?

Medicare Covers Adaptive Biotechnologies' ClonoSeq Assay

Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption

BioFluidica Applying Liquid Biopsy to Detect Leukemia While Reducing Biopsies

Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug

Liquid Biopsy Panel Expansion Enables Admera Health to Add Immunotherapy Prediction

Sponsorships